Application 219775

Type: ANDA
Sponsor: GLAND

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	INJECTABLE;INJECTION	EQ 500MG BASE/VIAL	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A219775-001	ACETAZOLAMIDE SODIUM	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP		2025-06-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A219775-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A219775-001	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2025-06-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A219775-001	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2025-06-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A219775-001	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2025-06-17	`6a471c1ec25d…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A219775-001	ACETAZOLAMIDE SODIUM	EQ 500MG BASE/VIAL	INJECTABLE / INJECTION	AP	2025-06-17	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A219775-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A219775-001	AP	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A219775-001	AP	1	`6a471c1ec25d…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A219775-001	AP	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Acetazolamide	ACETAZOLAMIDE SODIUM	Sagent Pharmaceuticals	58093032-8480-4d0f-82be-92e643bdbea4	2026-01-09	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 219775 application number: ANDA219775
Acetazolamide	ACETAZOLAMIDE	Gland Pharma Limited	2b9fb0dd-e42e-4f9b-bf24-98b268d877e5	2025-06-18	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 219775 application number: ANDA219775